Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure;Valor pronóstico comparativo del pro-péptido natriurético tipo B aminoterminal urinario en pacientes con insuficiencia cardiaca aguda descompensada

Revista Espanola de Cardiologia

Volumn 64, Issue 5, 2011, Pages 365-372

  Manzano Fernández, Sergio ^a   Januzzi, James L ^b   Boronat García, Miguel ^a   Bonaque González, Juan C ^a   Muñoz Esparza, Carmen ^a   Albaladejo Otón, María D ^a   Pastor Pérez, Francisco J ^a   Pastor, Patricia ^a   Valdés, Mariano ^a   Pascual Figal, Domingo A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Heart failure; Natriuretic peptide; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE DESTABILIZED HEART FAILURE; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; URINALYSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PEPTIDE FRAGMENTS; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; STROKE VOLUME;

EID: 79955585808     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.10.017     Document Type: Article

References (17)

1. Baggish AL, Van Kimmenade RR, Januzzi Jr JL. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure. Am J Cardiol. 2008;101:49-55.
2. Van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, Januzzi Jr JL. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol. 2006;98:386-90. (Pubitemid 44062449)
3. Januzzi JL, Van Kimmenade RR, Lainchbury J, Bayes-Genis A, Ordónez-Llanos J, Santaló-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330-7. (Pubitemid 43100029)
4. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-7. (Pubitemid 34764819)
5. Moe GW, Howlett J, Januzzi JL, Zowall H. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007;115:3103-10. (Pubitemid 46956499)
6. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-54. (Pubitemid 38364623)
7. Cortés R, Portolés M, Salvador A, Bertomeu V, García de Burgos F, Martínez-Dolz L, et al. Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail. 2006;8:621-7. (Pubitemid 44572958)
8. Cortés R, Rivera M, Salvador A, García de Burgos F, Bertomeu V, Roselló-Lletí E, et al. Urinary B-type natriuretic peptide levels in the diagnosis and prognosis of heart failure. J Card Fail. 2007;13:549-55. (Pubitemid 47362751)
9. Manzano-Fernández S, Boronat-García M, Baladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, et al. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol. 2009;103:1753-9.
10. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416. (Pubitemid 40283098)
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70.
12. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-72. (Pubitemid 351193639)
13. Ng LL, Loke IW, Davies JE, Geeranavar S, Khunti K, Stone MA, et al. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol. 2005;45:1043-50. (Pubitemid 40432437)
14. Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond). 2004;106:129-33. (Pubitemid 38223430)
15. Michielsen EC, Bakker JA, Kimmenade RR, Pinto YM, Dieijen-Visser MP. The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann Clin Biochem. 2008;45 Pt 4:389-94.
16. Linssen GC, Damman K, Hillege HL, Navis G, Van Veldhuisen DJ, Voors AA. Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation. 2009;120:35-41.
17. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004;50: 33-50. (Pubitemid 38125697)